company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15342000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15342000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15342000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1638000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8899000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10537000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4805000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,51000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,51000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4856000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4856000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4856000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,156000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4354000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,346000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1636000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2913000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1600000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 19:31:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15331000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15331000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15331000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1630000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9258000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10888000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4443000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,44000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-39000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4448000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4448000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4448000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,159000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,3972000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,317000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1651000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3017000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1700000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,2013-10-22 18:54:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.19
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8882000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8882000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8882000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2998000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13361000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16359000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7477000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,19000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-39000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7497000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7497000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7497000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,157000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7654000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1791000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.27
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1791000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.27
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1800000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.27
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14839000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14839000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14839000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3079000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13937000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17016000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2177000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-50000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-35000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2212000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2212000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2212000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,107000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2319000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9146000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,9146000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,9300000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,2013-07-31 19:31:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8444000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8444000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8444000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3587000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14584000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18171000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9727000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,23000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9704000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9704000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9704000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9704000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28406000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28406000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28500000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,2013-10-22 18:54:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,36317000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,36317000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36317000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4378000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15685000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20063000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16254000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,25000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,16279000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,349000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15930000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15930000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15930000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17049000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.64
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17049000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.64
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17000000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.64
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13391000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13391000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13391000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4956000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15347000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20303000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6912000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,12000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,28000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6884000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6884000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6884000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6884000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30959000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30959000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31300000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9494000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9494000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9494000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5306000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17499000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22805000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13311000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,26000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,12000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,38000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13273000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,113000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13386000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13386000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13386000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33500000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33500000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33156000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 08:10:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8177000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8177000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8177000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5669000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22244000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27913000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19736000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,24000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,17000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,41000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19695000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19700000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19700000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19700000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34000000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.58
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34000000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.58
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33676000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:40:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.58
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10349000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10349000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10349000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4935000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20505000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25440000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15091000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,29000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,18000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,47000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15044000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-9000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15035000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15035000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15035000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33027000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.47
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33027000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.47
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33027000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.47
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,911000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,911000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,911000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5237000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,57051000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62288000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-61377000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,20000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,51000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-61326000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61326000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61326000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-61326000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34992000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.75
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34992000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.75
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34992000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.75
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,736000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,736000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,736000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5970000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20551000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26521000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25785000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,20000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,26000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25759000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25759000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25759000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25759000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41087000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41087000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41087000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:19:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,358000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,358000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,358000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6676000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16788000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23464000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23106000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,21000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,41000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23065000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23065000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23065000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23065000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41461000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.56
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41461000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.56
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41461000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 06:43:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.56
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,555000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,555000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,555000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6017000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16819000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22836000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22281000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,37000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,18000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,55000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22226000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22226000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22226000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22226000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39839000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39839000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39839000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,472000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,472000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,472000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5846000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17740000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23586000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23114000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,220000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,15000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,235000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22879000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22879000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22879000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22879000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55149000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.41
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55149000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.41
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55149000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,473000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,473000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,473000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7424000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21450000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28874000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28401000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,404000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,16000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,420000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27981000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27981000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27981000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27981000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57352000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57352000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57352000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:01:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6584000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6584000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6584000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7522000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23888000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31410000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24826000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,469000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,21000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,490000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24336000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24336000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24336000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24336000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57970000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.42
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57970000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.42
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57970000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:07:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.42
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,478000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,478000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,478000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7580000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28383000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35963000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35485000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,438000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,31000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,469000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35016000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35016000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35016000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-35016000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57126000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.61
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57126000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.61
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57126000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.61
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8269000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24695000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32964000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32964000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,438000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,442000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32522000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32522000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32522000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32522000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58219000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.56
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58219000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.56
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58100000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.56
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10000000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10000000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10000000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11170000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27292000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38462000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28462000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,428000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,438000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28024000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28024000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28024000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28024000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58377000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.48
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58377000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.48
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58377000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 07:31:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.48
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 06:05:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 06:05:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9311000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 06:05:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28741000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 06:05:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38052000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 06:05:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38052000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 06:05:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,487000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 06:05:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-32000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 06:05:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,455000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 06:05:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37597000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 06:05:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37597000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 06:05:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37597000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 06:05:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37597000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 06:05:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59899000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 06:05:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 06:05:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59899000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 06:05:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 06:05:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59700000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 06:05:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8431000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28933000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37364000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37364000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,812000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,50000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,862000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-36502000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-336000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36166000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36166000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36166000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61471000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61471000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61471000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9360000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25622000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34982000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-34982000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,899000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,18000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,917000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34065000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34065000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34065000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34065000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69500000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69500000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,69386000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12000000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12000000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12000000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10914000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31346000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42260000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30260000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1143000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1132000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29128000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29128000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29128000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29128000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69400000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.42
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69400000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.42
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,69490000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 06:46:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.42
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11528000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27027000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38555000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38555000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1069000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1063000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37492000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37492000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37492000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37492000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69400000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.54
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69400000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.54
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,69539000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 16:07:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.54
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9700000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9700000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9700000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12170000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21838000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34008000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24308000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1446000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-26000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1420000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22888000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,57000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22945000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22945000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22945000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71864000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71864000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71864000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7891000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7891000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7891000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11986000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26896000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38882000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30991000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1658000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1652000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29339000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29339000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29339000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,2940000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32279000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,82424000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,82424000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82424000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.39
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5900000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5900000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5900000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15698000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40907000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,56605000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-50705000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2253000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-13000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2240000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-48465000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-48465000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48465000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-48465000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,91400000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.53
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,91400000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.53
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,90876000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 06:46:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.53
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5715000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5715000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5715000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17089000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26579000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43668000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37953000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1879000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1864000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-36089000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36089000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36089000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36089000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,90200000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,90200000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,91044000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 16:07:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4294000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4294000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4294000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23530000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38257000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61787000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-57493000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,192000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1320000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,21000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1149000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-56344000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,58000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-56402000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-56402000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-56402000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,89891000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.61
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,89891000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.61
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,89891000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.61
